אסטרדיול
הערות שוליים

↑  Ryan KJ (August 1982). "Biochemistry of aromatase: significance to female reproductive physiology". Cancer Research. 42 (8 Suppl): 3342s–3344s. PMID 7083198.
1 2  ד"ר ארדיטי אלכס- מאמר על הגדלה שפירה בערמונית
↑  Mechoulam R, Brueggemeier RW, Denlinger DL (September 1984). "Estrogens in insects". Cellular and Molecular Life Sciences. 40 (9): 942–944. doi:10.1007/BF01946450.
↑  Ozon R (1972). "Estrogens in Fishes, Amphibians, Reptiles, and Birds". In Idler DR. Steroids In Nonmammalian Vertebrates. Oxford: Elsevier Science. pp. 390–414. ISBN 978-0323140980.
1 2  Boron WF, Boulpaep EL (2003). Medical Physiology: A Cellular And Molecular Approach. Elsevier/Saunders. p. 1300. ISBN 978-1-4160-2328-9.
1 2 3  https://www.clalit.co.il/he/your_health/family/Pages/estradiol.aspx
↑  Rollerova, E., & Urbancikova, M. (2000). Intracellular estrogen receptors, their characterization and function. Endocr Regul, 34(4), 203-218.
1 2 3 4 5  הירש, ק' (2005). קרוטנואידים מעכבים סגנל של אסטרוגנים בתאי סרטן התלויים בהורמונים (חיבור לשם קבלת תואר "דוקטור לפילוסופיה"), אוניברסיטת בן-גוריון בנגב, באר שבע.
↑  Giguère, V., Tremblay, A., & Tremblay, G. B. (1998). Estrogen receptor β: re-evaluation of estrogen and antiestrogen signaling. Steroids, 63(5-6), 335-339.
↑  Saunders, P. T. (1998). Oestrogen receptor beta (ER beta). Reviews of reproduction, 3(3), 164-171.
↑  Paech, K., Webb, P., Kuiper, G. G., Nilsson, S., Gustafsson, J. Å., Kushner, P. J., & Scanlan, T. S. (1997). Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science, 277(5331), 1508-1510.
↑  Liu, M. M., Albanese, C., Anderson, C. M., Hilty, K., Webb, P., Uht, R. M., ... & Kushner, P. J. (2002). Opposing action of estrogen receptors α and β on cyclin D1 gene expression. Journal of Biological Chemistry, 277(27), 24353-24360.
↑  Lee, S. K., Choi, H. S., Song, M. R., Lee, M. O., & Lee, J. W. (1998). Estrogen receptor, a common interaction partner for a subset of nuclear receptors. Molecular Endocrinology, 12(8), 1184-1192.
↑  Mi-Ryoung, S. O. N. G., Soo-Kyung, L. E. E., Young-Woo, S. E. O., Hueng-Sik, C. H. O. I., LEE, J. W., & Mi-Ock, L. E. E. (1998). Differential modulation of transcriptional activity of oestrogen receptors by direct protein–protein interactions with retinoid receptors. Biochemical Journal, 336(3), 711-717.
↑  Liu, G., Schwartz, J. A., & Brooks, S. C. (1999). p53 down-regulates ER-responsive genes by interfering with the binding of ER to ERE. Biochemical and biophysical research communications, 264(2), 359-364.
↑  Wang, C., Fu, M., Angeletti, R. H., Siconolfi-Baez, L., Reutens, A. T., Albanese, C., ... & Fuqua, S. A. (2001). Direct acetylation of the estrogen receptor α hinge region by p300 regulates transactivation and hormone sensitivity. Journal of Biological Chemistry, 276(21), 18375-18383.
↑  Wells, L., Vosseller, K., & Hart, G. W. (2001). Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc. Science, 291(5512), 2376-2378.
↑  Kato, S., Endoh, H., Masuhiro, Y., Kitamoto, T., Uchiyama, S., Sasaki, H., ... & Metzger, D. (1995). Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science, 270(5241), 1491-1494.
↑  O’Lone, R., Frith, M. C., Karlsson, E. K., & Hansen, U. (2004). Genomic targets of nuclear estrogen receptors. Molecular endocrinology, 18(8), 1859-1875.
↑  Zhang, Z., & Teng, C. T. (2000). Estrogen receptor-related receptor α1 interacts with coactivator and constitutively activates the estrogen response elements of the human lactoferrin gene. Journal of Biological Chemistry, 275(27), 20837-20846.
↑  פרופ' סלע בן-עמי, הערך אסטרדיול באתר ויקירפואה.
↑  Wu CH, Motohashi T, Abdel-Rahman HA, Flickinger GL, Mikhail G (August 1976). "Free and protein-bound plasma estradiol-17 beta during the menstrual cycle". The Journal of Clinical Endocrinology and Metabolism. 43 (2): 436–45. doi:10.1210/jcem-43-2-436. PMID 950372.
↑  Stanczyk FZ, Archer DF, Bhavnani BR (June 2013). "Ethinyl estradiol and 17β-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment". Contraception. 87 (6): 706–27. doi:10.1016/j.contraception.2012.12.011. PMID 23375353.
↑  Falcone T, Hurd WW (2007). Clinical Reproductive Medicine and Surgery. Elsevier Health Sciences. pp. 22–. ISBN 978-0-323-03309-1.
↑  Oettel M, Schillinger E (6 December 2012). Estrogens and Antiestrogens I: Physiology and Mechanisms of Action of Estrogens and Antiestrogens. Springer Science & Business Media. pp. 235–237. ISBN 978-3-642-58616-3.
1 2  Craig CR, Stitzel RE (2004). Modern Pharmacology with Clinical Applications. Lippincott Williams & Wilkins. pp. 706–. ISBN 978-0-7817-3762-3.
1 2  McMillan JA, Feigin RD, DeAngelis C, Jones MD (2006). Oski's Pediatrics: Principles & Practice. Lippincott Williams & Wilkins. pp. 550–. ISBN 978-0-7817-3894-1.
↑  אצל נשים השומן מתחלק באופן שונה מגברים כאשר הוא מרוכז יותר באזור השד, האגן, הירכיים והעכוז.
↑  Victor R. Preedy (2 December 2011). Handbook of Growth and Growth Monitoring in Health and Disease. Springer Science & Business Media. pp. 2661–. ISBN 978-1-4419-1794-2.
↑  Carani C, Qin K, Simoni M, Faustini-Fustini M, Serpente S, Boyd J, Korach KS, Simpson ER (July 1997). "Effect of testosterone and estradiol in a man with aromatase deficiency". The New England Journal of Medicine. 337 (2): 91–5. doi:10.1056/NEJM199707103370204. PMID 9211678.
↑  Albright F, Smith PH, Richardson AM (31 May 1941). "Postmenopausal Osteoporosis: Its Clinical Features". JAMA. 116 (22): 2465–2474. doi:10.1001/jama.1941.02820220007002.
↑  Holzer G, Riegler E, Hönigsmann H, Farokhnia S, Schmidt JB, Schmidt B (September 2005). "Effects and side-effects of 2% progesterone cream on the skin of peri- and postmenopausal women: results from a double-blind, vehicle-controlled, randomized study". The British Journal of Dermatology. 153 (3): 626–34. doi:10.1111/j.1365-2133.2005.06685.x. PMID 16120154.
1 2  Raine-Fenning NJ, Brincat MP, Muscat-Baron Y (2003). "Skin aging and menopause : implications for treatment". American Journal of Clinical Dermatology. 4 (6): 371–8. doi:10.2165/00128071-200304060-00001. PMID 12762829.
↑  Response of skin thickness and metacarpal index to estradiol therapy in postmenopausal women. Obstetrics and gynecology 70 (4), 538-541, 1987
↑  Osterlund, M. et al. (1998) Differential distribution and regulation of estrogen receptor-alpha and -beta mRNA within the female rat brain. Brain Res. Mol. Brain Res. 54, 175–180
↑  Micevych, P. and Dominguez, R. (2009) Membrane estradiol signaling in the brain. Front. Neuroendocrinol. 30, 315–327
1 2  Almey, A. et al. (2015) Estrogen receptors in the central nervous system and their implication for dopamine-dependent cognition in females. Horm. Behav. 74, 125–138
↑  Borrow, A.P. and Cameron, N.M. (2014) Estrogenic mediation of serotonergic and neurotrophic systems: implications for female mood disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry 54, 13–25
↑  Frye, C.A. and Vongher, J.M. (1999) Progesterone has rapid and membrane effects in the facilitation of female mouse sexual behavior. Brain Res. 815, 259–269
↑  Sinchak, K. and Micevych, P.E. (2001) Progesterone blockade of estrogen activation of mu-opioid receptors regulates reproductive behavior. J. Neurosci. 21, 5723–5729
↑  Ervin, K.S. et al. (2015) Estrogen involvement in social behavior in rodents: rapid and long-term actions. Horm. Behav. 74, 53–76
↑  Bos, P.A. et al. (2012) Acute effects of steroid hormones and neuropeptides on human social-emotional behavior: a review of single administration studies. Front. Neuroendocrinol. 33, 17–35
↑  Li Y, Nakae K, Ishii S, Naoki H (2016) Uncertainty-Dependent Extinction of Fear Memory in an Amygdala-mPFC Neural Circuit Model. PLoS Comput Biol 12(9): e1005099. https://doi.org/10.1371/journal.pcbi.1005099
↑  Maeng, L.Y. and Milad, M.R. (2015) Sex differences in anxiety disorders: Interactions between fear, stress, and gonadal hormones. Horm. Behav. 76, 106–117
↑  Graham, B.M. and Milad, M.R. (2013) Blockade of estrogen by hormonal contraceptives impairs fear extinction in female rats and women. Biol. Psychiatry 73, 371–378
1 2  Zeidan, M.A. et al. (2011) Estradiol modulates medial prefrontal cortex and amygdala activity during fear extinction in women and
female rats. Biol. Psychiatry 70, 920–927
↑  Wegerer, M. et al. (2014) Low levels of estradiol are associated with elevated conditioned responding during fear extinction and
with intrusive memories in daily life. Neurobiol. Learn. Mem. 116, 145–154
↑  Hwang, M.J. et al. (2015) Contribution of estradiol levels and hormonal contraceptives to sex differences within the fear network
during fear conditioning and extinction. BMC Psychiatry 15, 295
↑  Amin, Z. et al. (2006) Effects of estrogen variation on neural correlates of emotional response inhibition. Neuroimage 32,
457–464
↑  Engman, J. et al. (2016) Amygdala subnuclei resting-state functional
connectivity sex and estrogen differences. Psychoneuroendocrinology 63, 34–42
↑  Jacobs, E.G. et al. (2015) 17beta-estradiol differentially regulates stress circuitry activity in healthy and depressed women. Neuropsychopharmacology 40, 566–576
↑  Goldstein, J.M. et al. (2005) Hormonal cycle modulates arousal circuitry in women using functional magnetic resonance imaging.
J. Neurosci. 25, 9309–9316
↑  Diekhof, E.K. (2015) Be quick about it. Endogenous estradiol
level, menstrual cycle phase and trait impulsiveness predict impulsive choice in the context of reward acquisition. Horm. Behav. 74, 186–193
↑  Justice, A.J. and de Wit, H. (2000) Acute effects of estradiol pretreatment on the response to d-amphetamine in women. Neuroendocrinology 71, 51–59
↑  Evans, S.M. and Foltin, R.W. (2006) Exogenous progesterone attenuates the subjective effects of smoked cocaine in women, but not in men. Neuropsychopharmacology 31, 659–674
↑  Kamboj, S.K. et al. (2015) A specific association between facial disgust recognition and estradiol levels in naturally cycling women. PLoS One 10, e0122311
↑  Guapo, V.G. et al. (2009) Effects of sex hormonal levels and phases of the menstrual cycle in the processing of emotional faces. Psychoneuroendocrinology 34, 1087–1094
↑  Karlsson, S. et al. (2016) Social memory associated with estrogen receptor polymorphisms in women. Soc. Cogn. Affect.
Neurosci. 11, 877–883
↑  Olsson, A. et al. (2016) Testosterone and estrogen impact social evaluations and vicarious emotions: a  double-blind placebo-controlled study. Emotion 16, 515–523
↑  Little, A.C. et al. (2007) Preferences for masculinity in male bodies change across the menstrual cycle. Horm. Behav. 51, 633–639
1 2  Penton-Voak, I.S. et al. (1999) Menstrual cycle alters face preference. Nature 399, 741–742
↑  Feinberg, D.R. et al. (2006) Menstrual cycle, trait estrogen level, and masculinity preferences in the human voice. Horm. Behav.
49, 215–222
↑  Grammer, K. (1993) 5-a-androst-16en-3a-on: a male pheromone? A brief report. Ethol. Sociol. 14, 201–207
↑  Gangstad, S.W. et al. (2004) Women's preferences for male behavioral displays change across the menstrual cycle. Psychol. Sci. 15, 203–207
↑  Gangstad, S.W. et al. (2004) Women's preferences for male behavioral displays change across the menstrual cycle. Psychol.
Sci. 15, 203–207
↑  Rupp, H.A. et al. (2009) Neural activation in the orbitofrontal cortex in response to male faces increases during the follicular
phase. Horm. Behav. 56, 66–72
↑  Hahn, A.C. and Perrett, D.I. (2014) Neural and behavioral
responses to attractiveness in adult and infant faces. Neurosci. Biobehav. Rev. 46 (Pt 4), 591–603
↑  Jones, B.C. et al. (2005) Commitment to relationships and preferences
for femininity and apparent health in faces are strongest on days of the menstrual cycle when progesterone level is high.  Horm. Behav. 48, 283–290
↑  Little, A.C. et al. (2013) Oral contraceptive use in women changes preferences for male facial masculinity and is associated with partner facial masculinity. Psychoneuroendocrinology 38, 1777–1785
↑  Fleischman, D.S. et al. (2010) Oral contraceptives suppress ovarian hormone production. Psychol. Sci. 21, 750–752 author reply 753
↑  Zimmerman, Y. et al. (2014) The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis. Hum. Reprod. Update 20, 76–105
↑  Rupp, H.A. and Wallen, K. (2007) Sex differences in viewing sexual stimuli: an eye-tracking study in men and women. Horm.
Behav. 51, 524–533
↑  Burrows, L.J. et al. (2012) The effects of hormonal contraceptives on female sexuality: a review. J. Sex. Med. 9, 2213–2223
↑  Georgiadis, J.R. and Kringelbach, M.L. (2012) The human sexual response cycle: brain imaging evidence linking sex to other pleasures. Prog. Neurobiol. 98, 49–81
↑  Georgiadis, J.R. and Kringelbach, M.L. (2012) The human sexual
response cycle: brain imaging evidence linking sex to other pleasures. Prog. Neurobiol. 98, 49–81
↑  Abler, B. et al. (2013) Neural correlates of erotic stimulation under different levels of female sexual hormones. PLoS One 8, e54447
↑  Russell, V.M. et al. (2014) The association between discontinuing
hormonal contraceptives and wives’ marital satisfaction depends on husbands’ facial attractiveness. Proc. Natl. Acad. Sci. U.S.A.
111, 17081–17086
↑  Welling, L.L. et al. (2012) Hormonal contraceptive use and mate retention behavior in women and their male partners. Horm. Behav. 61, 114–120
↑  Cobey, K.D. et al. (2011) Hormonal birth control use and relationship jealousy: evidence for estrogen dosage effects. Pers. Individ. Dif. 50, 315–317
↑  Roberts, S.C. et al. (2012) Relationship satisfaction and outcome in women who meet their partner while using oral contraception. Proc. Biol. Sci. 279, 1430–1436
↑  Roberts, S.C. et al. (2014) Partner choice, relationship satisfaction, and oral contraception: the congruency hypothesis. Psychol. Sci. 25, 1497–1503
↑  Scheele, D. et al. (2016) Hormonal contraceptives suppress oxytocin-induced brain reward responses to the partner's face. Soc. Cogn. Affect. Neurosci. 11, 767–774
↑  Sprengelmeyer, R. et al. (2009) The cutest little baby face: a hormonal link to sensitivity to cuteness in infant faces. Psychol.
Sci. 20, 149–154
↑  Mascaro, J.S. et al. (2014) Differential neural responses to child and sexual stimuli in human fathers and non-fathers and their
hormonal correlates. Psychoneuroendocrinology 46, 153–163
1 2  Brinkmann, A. O. (2001). Molecular basis of androgen insensitivity. Molecular and cellular endocrinology, 179(1-2), 105-109.
1 2  Oakes, M. B., Eyvazzadeh, A. D., Quint, E., & Smith, Y. R. (2008). Complete androgen insensitivity syndrome—a review. Journal of pediatric and adolescent gynecology, 21(6), 305-310.
↑  J. Larry Jameson; Leslie J. De Groot (25 February 2015). Endocrinology: Adult and Pediatric. Elsevier Health Sciences. pp. 238–. ISBN 978-0-323-32195-2.
1 2  Bernard V, Kherra S, Francou B, Fagart J, Viengchareun S, Guéchot J, Ladjouze A, Guiochon-Mantel A, Korach KS, Binart N, Lombès M, Christin-Maitre S (2017). "Familial Multiplicity of Estrogen Insensitivity Associated With a Loss-of-Function ESR1 Mutation". J. Clin. Endocrinol. Metab. 102 (1): 93–99. doi:10.1210/jc.2016-2749. PMC 5413105. PMID 27754803.
↑  P.Jones,P.Buckley (2006) ע' 7
1 2  Kraepelin, E., Psychiatry, 1909–13. 8th edition. Leipzig.
1 2  McGregor, C., Riordan, A., & Thornton, J. (2017). Estrogens and the cognitive symptoms of schizophrenia: possible neuroprotective mechanisms. Frontiers in neuroendocrinology, 47, 19-33.
1 2  Newton-Mann, E., Finney, C., Purves-Tyson, T., & Gogos, A. (2017). Estrogen receptors: mechanism of action and relevance to schizophrenia. Current Psychiatry Reviews, 13(1), 55-64.
↑  Kretschmer, E. (1936). Körperbau und Charakter. Untersuchungen zum Konstitutions-Problem und zur Lehre von den Temperamenten.
↑  Riecher-Rössler, A., & Häfner, H. (1993). Schizophrenia and oestrogens—is there an association?. European Archives of Psychiatry and Clinical Neuroscience, 242(6), 323-328.
↑  Commission on Epidemiology and Prognosis, International League Against Epilepsy (1993). "Guidelines for epidemiologic studies on epilepsy". Epilepsia. 34 (4): 592–6. doi:10.1111/j.1528-1157.1993.tb00433.x. PMID 8330566.(הקישור אינו פעיל)
↑  Temkin, Owsei (1 במרץ 1994) [First published 1945, Revised 1971]. The Falling Sickness (2nd Revised ed.). Baltimore: Johns Hopkins University Press. ISBN 978-0801848490. {{cite book}}:  (עזרה)
↑  Backstrom T (1976). "Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle". Acta neurologica Scandinavica. 54 (4): 321–47. doi:10.1111/j.1600-0404.1976.tb04363.x. PMID 973554.
↑  Riazi K, Honar H, Homayoun H, Rashidi N, Dehghani M, Sadeghipour H, Gaskari SA, Dehpour AR (2004). "Sex and estrus cycle differences in the modulatory effects of morphine on seizure susceptibility in mice". Epilepsia. 45 (9): 1035–42. doi:10.1111/j.0013-9580.2004.69903.x. PMID 15329066.{{cite journal}}:  תחזוקה - ציטוט: multiple names: authors list (link)
↑  Koh KK, Horne MKIII, Cannon ROIII. Effects of hormone replacement therapy on coagulation, fibrinolysis, and thrombosis risk in postmenopausal women. Thromb Haemost. 1999; 82: 626–633.
↑  Teede HJ, McGrath BP, Smolich JJ, Malan E, Kotsopoulos D, Liang YL, Peverill RE. Postmenopausal hormone replacement therapy increases coagulation activity and fibrinolysis. Arterioscler Thromb Vasc Biol. 2000; 20: 1404–1409.
1 2 3  Asscheman, H., T'Sjoen, G., Lemaire, A., Mas, M., Meriggiola, M. C., Mueller, A., ... & Gooren, L. J. (2014). Venous thrombo‐embolism as a complication of cross‐sex hormone treatment of male‐to‐female transsexual subjects: a review. Andrologia, 46(7), 791-795.
1 2 3  Weinand, J. D., & Safer, J. D. (2015). Hormone therapy in transgender adults is safe with provider supervision; a review of hormone therapy sequelae for transgender individuals. Journal of clinical & translational endocrinology, 2(2), 55-60.
↑  Jick H, Kaye JA, Vasilakis-Scaramozza C, Jick SS. Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysis. BMJ. 2000; 321: 1190–1195.
↑  Bloemenkamp KWM, Rosendaal FR, Büller HR, Helmerhorst FM, Colly LP, Vandenbroucke JP. Risk of venous thrombosis with use of current low-dose oral contraceptives is not explained by diagnostic suspicion and referral bias. Arch Intern Med. 1999; 159: 65–70.
↑  Kemmeren JM, Algra A, Grobbee DE. Third generation oral contraceptives and risk of venous thrombosis: meta-analysis. BMJ. 2001; 323: 131–134.
1 2  Olivieri O, Friso S, Manzato F, Guella A, Bernardi F, Lunghi B, Girelli D, Azzini M, Brocco G, Russo C. Resistance to activated protein C in healthy women taking oral contraceptives. Br J Haematol. 1995; 91: 465–470.
1 2  Scarabin PY, Plu-Bureau G, Zitoun D, Bara L, Guize L, Samama MM. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity. Thromb Haemost. 1995; 74: 928–932.
1 2 3 4 5 6 7  הערך על טיפול הורמונלי, אתר מעברים - שינוי בר קיימא לאוכלוסייה הטרנסית
1 2 3  Giltay, E. J., & Gooren, L. J. G. (2000). Effects of sex steroid deprivation/administration on hair growth and skin sebum production in transsexual males and females. The Journal of Clinical Endocrinology & Metabolism, 85(8), 2913-2921.
1 2  דף מרפאת הטרנסג'נדרים באתר בית החולים בני ציון
↑  Jones, I., Chandra, P. S., Dazzan, P., & Howard, L. M. (2014). Bipolar disorder, affective psychosis, and schizophrenia in pregnancy and the post-partum period. The Lancet, 384(9956), 1789-1799.
↑  Balaraman Y, Schmetzer AD. Hormonal replacement therapy in postpartum affective disorders. Ann Clin Psychiatry. 2011;23:71–72.
↑  Huang MC, Wang YB, Chan CH. Estrogen-progesterone combination for treatment-refractory post-partum mania. Psychiatry Clin Neurosci. 2008;62:126.
1 2  Davies, W. (2017). Understanding the pathophysiology of postpartum psychosis: challenges and new approaches. World journal of psychiatry, 7(2), 77.
↑  Barth, C., Villringer, A., & Sacher, J. (2015). Sex hormones affect neurotransmitters and shape the adult female brain during hormonal transition periods. Frontiers in neuroscience, 9, 37.
↑  אתי הרמתי, 51 שנה לאישור השימוש בקלומיפן ציטראט, התרופה שסללה את הדרך להיריון אצל נשים רבות בעלות ביוץ לא סדיר,  באתר של מכון דוידסון לחינוך מדעי, 7 בפברואר 2018.
1 2 3 4  Simpson, E., & Santen, R. J. (2015). Celebrating 75 years of oestradiol. Journal of molecular endocrinology, 55(3), T1-T20.
↑  הדף על בוטנאנדט באתר פרסי נובל
| הורמונים |
| --- | --- | --- |
| היפותלמוס ובלוטת יותרת המוח | הורמון משחרר תירוטרופין (TRH)‏ • CRH‏ • GnRH •‏ הורמון משחרר הורמון גדילה (GHRH) • סומטוסטטין (SST) • דופמין • וזופרסין (ADH) • אוקסיטוצין • תירוטרופין (TSH) • הורמון מחלמן (LH) • הורמון מגרה זקיק (FSH) • הורמון הגדילה (GH) • פרולקטין (PRL) • הורמון אדרנוקורטיקוטרופי (ACTH) |  |
| ציר בלוטת יותרת הכליה | אדרנלין (אפינפרין) • נוראדרנלין (נוראפינפרין) • אלדוסטרון • קורטיזול • דהידרו-אפיאנדרוסטרון (DHEA) |  |
| ציר בלוטת התריס | בלוטת התריס: תירוקסין • תריודוטירונין • קלציטונין • בלוטת יותרת התריס: PTH |  |
| ציר בלוטות המין | אשכים: טסטוסטרון • AMH • אינהיבין.  שחלות: אסטרדיול • פרוגסטרון • אינהיבין/אקטיבין • רלקסין |  |
| בלוטות אנדוקריניות אחרות | לבלב: גלוקגון • אינסולין • סומטוסטטין. בלוטת האצטרובל: מלטונין |  |
| בלוטות לא אנדוקריניות | שליה: גונדוטרופין כוריוני אנושי (hCG)‏ • HPL • אסטרוגן (אסטריול, אסטרדיול, אסטרון) • פרוגסטרון. כליה: רנין • אריתרופויאטין (EPO) • קלציטריול • פרוסטגלנדין. חדרי הלב: ANP. קיבה: גסטרין • גרלין. תריסריון: כולציסטוקינין (CCK)‏ • GIP • סקרטין • מוטילין • VIP. המעי העקום: אנטרוגלוקגון. רקמות שומן: לפטין • אדיפונקטין • רסיסטין. התימוס: תימוסין • תימופואיטין • תימולין. שלד: אוסטאוקלצין. כבד: IGF-1‏ • IGF-2 |  |
| נוצרים באתר המטרה | NGF • BDNF • NT-3 |  |
| --- | --- |
בקרת זהויות :  NLI: 987007555683305171  BNE: XX549447  BnF: cb122583059 (data)  GND: 4172466-5  LCCN: sh85045006 
דימר אזור קשירת הליגנד של קולטן אסטרוגן מסוג אלפא (ERα)
נתיבים מרכזיים במטבוליזם של אסטרדיול בגוף האדם
הבדלים אנטומיים בין גברים לנשים
שינויים ברמות האסטרדיול בגוף האישה לאורך המחזור, המושווה בין מחזורים שונים ובין נשים.
התמונה מציגה את ההבדל שבין דחיסות העצם הבריאה והעצם החולה בדלדול עצם היכול להיגרם מחוסר באסטרדיול.
התרשים המסומן באות E הוא מודל מוצע למעגלים מוחיים המווסתים למידת פחד. ניתן לראות בירוק את ה-vmPFC אשר מתואר כיחידה המשפעלת אזור באמיגדלה הנקרא ITC, אשר בתורו מדכא את הגרעין המרכזי של האמיגדלה (CEA). גרעין זה ידוע כמעורב בהוצאה לפועל של תגובת פחד. התרשים לקוח מתוך: (Li Y, Nakae K, Ishii S, Naoki H (2016
אדוורד דוייזי מגלה האסטרדיול